These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34244600)

  • 1. Novel PRMT7 mutation in a rare case of dysmorphism and intellectual disability.
    Poquérusse J; Whitford W; Taylor J; Alburaiky S; Snell RG; Lehnert K; Jacobsen JC
    J Hum Genet; 2022 Jan; 67(1):19-26. PubMed ID: 34244600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding the clinical and molecular spectrum of PRMT7 mutations: 3 additional patients and review.
    Agolini E; Dentici ML; Bellacchio E; Alesi V; Radio FC; Torella A; Musacchia F; Tartaglia M; Dallapiccola B; Nigro V; Digilio MC; Novelli A
    Clin Genet; 2018 Mar; 93(3):675-681. PubMed ID: 28902392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further delineation of the phenotype caused by loss of function mutations in PRMT7.
    Valenzuela I; Segura-Puimedon M; Rodríguez-Santiago B; Fernández-Alvarez P; Vendrell T; Armengol L; Tizzano E
    Eur J Med Genet; 2019 Mar; 62(3):182-185. PubMed ID: 30006058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biallelic PRMT7 pathogenic variants are associated with a recognizable syndromic neurodevelopmental disorder with short stature, obesity, and craniofacial and digital abnormalities.
    Cali E; Suri M; Scala M; Ferla MP; Alavi S; Faqeih EA; Bijlsma EK; Wigby KM; Baralle D; Mehrjardi MYV; Schwab J; Platzer K; Steindl K; Hashem M; Jones M; Niyazov DM; Jacober J; Littlejohn RO; Weis D; Zadeh N; Rodan L; Goldenberg A; Lecoquierre F; Dutra-Clarke M; Horvath G; Young D; Orenstein N; Bawazeer S; Vulto-van Silfhout AT; Herenger Y; Dehghani M; Seyedhassani SM; Bahreini A; Nasab ME; Ercan-Sencicek AG; Firoozfar Z; Movahedinia M; Efthymiou S; Striano P; Karimiani EG; Salpietro V; Taylor JC; Redman M; Stegmann APA; Laner A; Abdel-Salam G; Li M; Bengala M; Müller AJ; Digilio MC; Rauch A; Gunel M; Titheradge H; Schweitzer DN; Kraus A; Valenzuela I; McLean SD; Phornphutkul C; Salih M; Begtrup A; Schnur RE; Torti E; Haack TB; Prada CE; Alkuraya FS; Houlden H; Maroofian R
    Genet Med; 2023 Jan; 25(1):135-142. PubMed ID: 36399134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of the arginine methyltranserase PRMT7 causes syndromic intellectual disability with microcephaly and brachydactyly.
    Kernohan KD; McBride A; Xi Y; Martin N; Schwartzentruber J; Dyment DA; Majewski J; Blaser S; ; Boycott KM; Chitayat D
    Clin Genet; 2017 May; 91(5):708-716. PubMed ID: 27718516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short stature in PRMT7 Mutations: first evidence of response to growth hormone treatment.
    Rodari G; Villa R; Porro M; Gangi S; Iascone M; Elli F; Giacchetti F; Profka E; Collini V; Dall'Antonia A; Arosio M; Mantovani G; Bedeschi MF; Giavoli C
    Eur J Hum Genet; 2023 Feb; 31(2):195-201. PubMed ID: 36348013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal and postnatal presentation of PRMT7 related syndrome: Expanding the phenotypic manifestations.
    Birnbaum R; Yosha-Orpaz N; Yanoov-Sharav M; Kidron D; Gur H; Yosovich K; Lerman-Sagie T; Malinger G; Lev D
    Am J Med Genet A; 2019 Jan; 179(1):78-84. PubMed ID: 30513135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biallelic variants in FBXL3 cause intellectual disability, delayed motor development and short stature.
    Ansar M; Paracha SA; Serretti A; Sarwar MT; Khan J; Ranza E; Falconnet E; Iwaszkiewicz J; Shah SF; Qaisar AA; Santoni FA; Zoete V; Megarbane A; Ahmed J; Colombo R; Makrythanasis P; Antonarakis SE
    Hum Mol Genet; 2019 Mar; 28(6):972-979. PubMed ID: 30481285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OTUD6B-associated intellectual disability: novel variants and genetic exclusion of retinal degeneration as part of a refined phenotype.
    Abdel-Salam GMH; Abdel-Hamid MS; Sayed ISM; Zechner U; Bolz HJ
    J Hum Genet; 2022 Jan; 67(1):55-64. PubMed ID: 34354232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic screening in rare disorders: New mutations and phenotypes, highlighting ALG14 as a novel cause of severe intellectual disability.
    Kvarnung M; Taylan F; Nilsson D; Anderlid BM; Malmgren H; Lagerstedt-Robinson K; Holmberg E; Burstedt M; Nordenskjöld M; Nordgren A; Lundberg ES
    Clin Genet; 2018 Dec; 94(6):528-537. PubMed ID: 30221345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel ANKRD11 gene mutation in an individual with a mild phenotype of KBG syndrome associated to a GEFS+ phenotypic spectrum: a case report.
    Alves RM; Uva P; Veiga MF; Oppo M; Zschaber FCR; Porcu G; Porto HP; Persico I; Onano S; Cuccuru G; Atzeni R; Vieira LCN; Pires MVA; Cucca F; Toralles MBP; Angius A; Crisponi L
    BMC Med Genet; 2019 Jan; 20(1):16. PubMed ID: 30642272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPT2 mutations in autosomal recessive developmental disability: extending the clinical phenotype and population prevalence estimates.
    Ouyang Q; Kavanaugh BC; Joesch-Cohen L; Dubois B; Wu Q; Schmidt M; Baytas O; Pastore SF; Harripaul R; Mishra S; Hussain A; Kim KH; Holler-Managan YF; Ayub M; Mir A; Vincent JB; Liu JS; Morrow EM
    Hum Genet; 2019 Oct; 138(10):1183-1200. PubMed ID: 31471722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZMYND11-related syndromic intellectual disability: 16 patients delineating and expanding the phenotypic spectrum.
    Yates TM; Drucker M; Barnicoat A; Low K; Gerkes EH; Fry AE; Parker MJ; O'Driscoll M; Charles P; Cox H; Marey I; Keren B; Rinne T; McEntagart M; Ramachandran V; Drury S; Vansenne F; Sival DA; Herkert JC; Callewaert B; Tan WH; Balasubramanian M
    Hum Mutat; 2020 May; 41(5):1042-1050. PubMed ID: 32097528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exome sequencing reveals a novel CWF19L1 mutation associated with intellectual disability and cerebellar atrophy.
    Evers C; Kaufmann L; Seitz A; Paramasivam N; Granzow M; Karch S; Fischer C; Hinderhofer K; Gdynia G; Elsässer M; Pinkert S; Schlesner M; Bartram CR; Moog U
    Am J Med Genet A; 2016 Jun; 170(6):1502-9. PubMed ID: 27016154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole exome sequencing identified a novel missense alteration in CC2D2A causing Joubert syndrome 9 in a Pakhtun family.
    Khan MI; Latif M; Saif M; Ahmad H; Khan AU; Naseer MI; Hussain HMJ; Jelani M
    J Gene Med; 2021 Jan; 23(1):e3279. PubMed ID: 32989887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delineating the phenotypic spectrum of hyperphosphatasia with mental retardation syndrome 4 in 14 patients of Middle-Eastern origin.
    Balobaid A; Ben-Omran T; Ramzan K; Altassan R; Almureikhi M; Musa S; Al-Hashmi N; Al-Owain M; Al-Zaidan H; Al-Hassnan Z; Imtiaz F; Al-Sayed M
    Am J Med Genet A; 2018 Dec; 176(12):2850-2857. PubMed ID: 30345601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel variant of C12orf4 in a consanguineous Armenian family confirms the etiology of autosomal recessive intellectual disability type 66 with delineation of the phenotype.
    Hancarova M; Babikyan D; Bendova S; Midyan S; Prchalova D; Shahsuvaryan G; Stranecky V; Sarkisian T; Sedlacek Z
    Mol Genet Genomic Med; 2019 Sep; 7(9):e865. PubMed ID: 31334606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel homozygous DPH1 mutation causes intellectual disability and unique craniofacial features.
    Sekiguchi F; Nasiri J; Sedghi M; Salehi M; Hosseinzadeh M; Okamoto N; Mizuguchi T; Nakashima M; Miyatake S; Takata A; Miyake N; Matsumoto N
    J Hum Genet; 2018 Apr; 63(4):487-491. PubMed ID: 29410513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole genome sequencing of consanguineous families reveals novel pathogenic variants in intellectual disability.
    Thuresson AC; Soussi Zander C; Zhao JJ; Halvardson J; Maqbool K; Månsson E; Stenninger E; Holmlund U; Öhrner Y; Feuk L
    Clin Genet; 2019 Mar; 95(3):436-439. PubMed ID: 30525197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eight further individuals with intellectual disability and epilepsy carrying bi-allelic CNTNAP2 aberrations allow delineation of the mutational and phenotypic spectrum.
    Smogavec M; Cleall A; Hoyer J; Lederer D; Nassogne MC; Palmer EE; Deprez M; Benoit V; Maystadt I; Noakes C; Leal A; Shaw M; Gecz J; Raymond L; Reis A; Shears D; Brockmann K; Zweier C
    J Med Genet; 2016 Dec; 53(12):820-827. PubMed ID: 27439707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.